NCT02575690View on ClinicalTrials.gov

Spirulina Supplementation and Cardiovascular Risk in Obese Caucasians With Treated Hypertension

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2016

Conditions
Obesity
Interventions
DIETARY_SUPPLEMENT

Spirulina

Individuals receive 2 g of spirulina daily, for 3 months.

OTHER

Placebo

Individuals receive a placebo daily, for 3 months.

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER

NCT02575690 - Spirulina Supplementation and Cardiovascular Risk in Obese Caucasians With Treated Hypertension | Biotech Hunter | Biotech Hunter